Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion
NASDAQ:OPRX

OptimizeRx 1/31/2026 Earnings Report

OptimizeRx logo
$4.94 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$4.97 +0.03 (+0.71%)
As of 05/22/2026 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

OptimizeRx EPS Results

Actual EPS
$0.51
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OptimizeRx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OptimizeRx Announcement Details

Quarter
Date
1/31/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

OptimizeRx's Q2 2026 earnings is estimated for Thursday, August 6, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

OptimizeRx Earnings Headlines

DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 22 at 2:18 PM  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/deepintent-becomes-first-healthcare-dsp-to-integrate-optimizerx-s-authenticated-ehr-network-1036183094
OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform
May 21 at 7:50 AM  |  quiverquant.comQ
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel
May 24 at 1:00 AM  |  Porter & Company (Ad)
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network
May 21 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/21/3299209/0/en/deepintent-becomes-first-healthcare-dsp-to-integrate-optimizerx-s-authenticated-ehr-network.html
OptimizeRx Corp. (NASDAQ:OPRX) Given Average Recommendation of "Moderate Buy" by Analysts
May 18, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30785334
Wall Street Zen Downgrades OptimizeRx (NASDAQ:OPRX) to Buy
May 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30780830
See More OptimizeRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email.

About OptimizeRx

OptimizeRx (NASDAQ:OPRX), Inc. is a healthcare technology company that operates a digital health network designed to facilitate communication between pharmaceutical manufacturers, payers and healthcare providers. Through its cloud-based platform, OptimizeRx delivers targeted digital interventions—such as patient savings messages, clinical content and product information—directly into electronic health record (EHR) workflows at the point of care. By integrating with leading EHR systems, the company helps life sciences organizations optimize brand engagement, improve patient adherence and support informed prescribing decisions.

The company’s core offerings include digital prescription benefit notifications, co-pay assistance alerts and real-time clinical messaging tailored to specific patient populations. These tools allow pharmaceutical and biotechnology firms to deliver personalized messaging to physicians and care teams, ensuring that relevant formulary and financial support information is accessible at the moment of treatment. In addition, OptimizeRx provides data analytics and reporting capabilities that enable clients to measure the impact of their digital outreach and refine strategies to drive prescription growth and patient outcomes.

Founded in 2003 and headquartered in Cleveland, Ohio, OptimizeRx has formed partnerships with a broad spectrum of EHR vendors and health systems across the United States. The company’s network reaches tens of thousands of healthcare providers, making it one of the largest point-of-care communication platforms in the country. OptimizeRx collaborates closely with payers to integrate eligibility and benefit information, ensuring that savings offers and coverage details are accurate and up to date.

OptimizeRx is led by Chief Executive Officer David Whitlinger, who joined the company in 2019 and has overseen its expansion of digital service offerings and strategic alliances. Under his leadership, the company has focused on enhancing interoperability, scaling its network footprint and delivering advanced analytics to clients. While its primary market remains the U.S., OptimizeRx continues to explore opportunities to extend its digital health network into new regions and therapeutic areas.

View OptimizeRx Profile
Earnings Tools